Storage solution containing fructose-1,6-bisphosphate inhibits the excess activation of Kupffer cells in cold liver preservation

Transplantation

Volumn 74, Issue 6, 2002, Pages 779-783

  Hirokawa, Fumitoshi ^a   Nakai, Takehiro ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; FLUORESCEIN; FRUCTOSE 1,6 BISPHOSPHATE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PRESERVATION SOLUTION; TUMOR NECROSIS FACTOR ALPHA; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROTECTION; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; KUPFFER CELL; LIVER PRESERVATION; LIVER PROTECTION; MALE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

EID: 0037183853     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209270-00008     Document Type: Article

References (35)

1. Wahlberg JA, Southard JH, Belzer FO. Development of a cold storage solution for pancreas preservation. Cryobiology 1987; 23: 477.
2. Furukawa H, Todo S, Inventarza O. Effect of cold ischemic time on early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991; 51: 1000.
3. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts: An overview and synthesis of current studies. Transplantation 1992; 53: 957.
4. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers. Hepatology 1991; 13: 83.
5. Sumimoto R, Jamieson NV, Kamada N. Examination of role of impermeant lactobionate and raffinose in a simplified UW solution. Transplantation 1990; 50: 573.
6. Howden BO, Jablonski P, Thomas AC, et al. Liver preservation with UW solution. I. Evidence that hydroxyethyl starch is not essential. Transplantation 1990; 49: 869.
7. Wiltrout RH, Mathieson BJ, Talmadge JE, et al. Augmentation of organ associated natural killer activity by biological response modifiers: Isolation and characterization of large granular lymphocytes from the liver. J Exp Med 1984; 160: 1431.
8. Kasahara T, Mukaida N, Shinomiya H, et al. Preparation and characterization of polyclonal and monoclonal antibodies against human interleukin 1-α. J Immunol 1987; 138: 1804.
9. Rockett KA, Awburn MM, Cowden WB, Clark IA. Killing of plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun 1991; 59: 3280.
10. Ogawa Y, Imoto M, Fukuda Y, et al. Influence of prostaglandin to the endotoxin taking-in ability of Kupffer cells. In: Tanigawa H, ed. Progress in hepatic sinusoidal cell studies, vol. 4. Tokyo, Kokusai Isho Shuppan Ltd. Medical Publishers Version, 1992, p 58.
11. Marzi I, Zhong Z, Lemasters JJ, Thurman RG. Evidence that graft survival is not related to parenchymal cell viability in rat liver transplantation: The importance of nonparenchymal cells. Transplantation 1989; 48: 463.
12. Tavazzi B, Starnes JW, Lazzarino G, Di Pierro D, Nuutinen EM, Giardina B. Exogenous fructose-1,6-diphosphate is a metabolizable substrate for the isolated normoxic rat heart. Basic Res Cardiol 1992; 87: 280.13.
13. Ehringer WD, Chiang B, Chien S. The uptake and metabolism of fructose1,6-diphosphate in rat cardiomyocytes. Mol Cell Biochem 2001; 221: 33.
14. Takeuchi K, Cao-Danh H, Friehs I, et al. Administration of fructose 1,6-diphosphate during early reperfusion significantly improves recovery of contractile function in the postischemic heart. Thorac Cardiovasc Surg 1998; 116: 335.
15. Cardenas A, Hurtado O, Leza JC, et al. Fructose-1,6-bisphosphate inhibits the expression of inducible nitric oxide synthase caused by oxygen-glucose deprivation through the inhibition of glutamate release in rat forebrain slices. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: 208.
16. Edde L, Zhou X, Eaton JW, Sharman MP. Induction of nitric oxide synthase in macrophages: Inhibition by fructose-1,6-diphosphate. Biochem Biophys Res Commun 1998; 243: 683.
17. Markov AK, Oglethope N, Grogan JB, Harpper KH. Effect of fructose-1,6-diphosphate on the phagocytic function of rat RES and on human leukocyte carbohydrate metabolism. Am J Med 1985; 290: 3.
18. Schinetti ML, Lazzarino G. Inhibition of phorbol ester-stimulated chemiluminescence and superoxide production in human neutrophils by fructose-1,6-diphosphate. Biochem Pharmacol 1986; 35: 1762.
19. Nakai T, Tanimura H, Tabuse K, Nagai Y, Mori K, Yamoto H. Beneficial effects of fructose-1,6-diphosphate infusion on cellular viability in ischemic liver injury. Gastroenterol Jpn 1991; 26: 611.
20. Torras J, Borobia FG, Herrero I, et al. Hepatic preservation with a cold-storage solution containing fructose-1,6-diphosphate and mannitol: Evaluation with the isolated perfused rat liver and comparison with University of Wisconsin solution. Transplant Proc 1995; 27: 2379.
21. Herrero I, Torras J, Carrera M, et al. Evaluation of a preservation solution containing fructose-1,6-diphosphate and mannitol using the isolated perfused rat kidney: Comparison with Euro-Collins and University of Wisconsin solutions. Nephrol Dial Transplant 1995; 10: 519.
22. Meltzer MS. Tumor cytotoxicity by lymphokine-activated macrophages: development of macrophage tumoricidal activity requires a sequence of reaction. In: Pick E, ed. Lymphokines 3. New York, Academic Press, 1981, p 319.
23. Johnson WJ, Marino PA, Schreiber RD, Adams DO. Sequential activation of murine mononuclear phagocytes for tumor cytolysis: Differential expression of markers by macrophages in the several stages of development. J Immunol 1983; 131: 1038.
24. Watanabe K, Kinoshita S, Nakagawa H. Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelial cell line of normal rat kidney (NRK-52E cell). Biochem Biophys Res Commun 1989; 161: 1093.
25. Hisama N, Yamaguchi Y, Ogawa M, et al. Kupffer cell production of cytokine-induced neutrophil chemoattractant (CINC) following ischemia reperfusion injury in rats. Hepatology 1996; 24: 1193.
26. Laskin DL, Rodriguez del Valle M, Heck DE, et al. Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression. Hepatology 1995;22:223.
27. Kurose I, Kato S, Ishii H, et al. Nitric oxide mediates lipopolysaccharide-induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver. Hepatology 1993; 18: 380.
28. Billiar TR, Curran RD, Ferrari FK, Williams DL, Simmons RL. Kupffer cell: Hepatocyte cocultures release nitric oxide in response to bacterial endotoxin. J Surg Res 1990; 48: 349.
29. Marzi I, Cowper K, Takei Y, Lindert K, Lemasters JJ, Thurman RG. Methyl palmitate prevents Kupffer cell activation and improves survival after orthotopic liver transplantation in the rat. Transpl Int 1991; 4: 215.
30. Suzuki S, Nakamura S, Sakaguti T, et al. Alternation of reticuloendothelial phagocytic function and tumor necrosis factor production after total hepatic ischemia. Transplantation 1997; 64: 821.
31. Roig T, De Oliveira JR, Bartrons R, Bermudez J. Fructose 1,6-bisphosphate protects against D-galactosamine toxicity in isolated rat hepatocytes. Am J Physiol 1994; 266: C1722.
32. Moghimi SM, Patel HM. Calcium as a possible modulator of Kupffer cell phagocytic function by regulating liver-specific opsonic activity. Biochim Biophys Acta 1990; 1028: 304.
33. Hotchkiss RS, Osborne DF, Lappas GD, Karl IE. Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-α, interleukin-1β, and interleukin-1α in a mouse model of endotoxin. Shock 1995; 3: 337.
34. 2+ modulation with fructose-1,6-bisphosphate during in vitro hypoxia-ischemia involves phospholipase C-dependent signaling. Brain Res 2001; 917: 158.
35. 2+-transport ATPase. J Neurochem 1999; 72: 81.